Tag:
V3381
Latest Headlines
Latest Headlines
Vernalis spikes troubled V3381 program
The U.K'.s Vernalis says that interim data from a pilot study of V3381 for chronic cough along with the data from a Phase IIb study in neuropathic pain convinced the developer to spike any further
Vernalis shares dive after pain program flunks PhIIb
Shares of Vernalis tumbled about 20 percent this morning after the UK developer announced that one of its experimental drugs failed a Phase IIb clinical trial for diabetes-related neuropathic pain.
